Final analysis results from TITAN: A phase III study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT).

Tarih
2021
Yazar
Merseburger, Axel Stuart
Chi, Kim N.
Chowdhury, Simon
Bjartell, Anders
Chung, Byung Ha
de Santana Gomes, Andrea Juliana Pereira
Given, Robert
Soto, Alvaro Juarez
ÖZGÜROĞLU, Mustafa
Uemura, Hirotsugu
Ye Dingwei, Ye Dingwei
Triantos, Spyros
Mundle, Suneel
McCarthy, Sharon Anne
Larsen, Julie S.
Sun Weili, Sun Weili
Bevans, Katherine
Zhang Ke, Zhang Ke
Bandyopadhyay, Nibedita
Agarwal, Neeraj
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/168206
https://doi.org/10.1200/jco.2021.39.6_suppl.11
Koleksiyonlar